Kyverna Therapeutics · Sell signal under management
Kyverna Therapeutics nearly flat (-0.5%): double bottom holds as buyers return
Kyverna Therapeutics · Sell signal under management
Our view last week
Kyverna Therapeutics' sell signal has teeth again: after last week's bounce, the week just closed shed 12.2%, with 80% of volume back on the sell side and money flow sinking deeply negative once more. The daily chart still carved out a double bottom in the 7.3 area, with an intermediate 43% rebound before sellers took back control. The short, under pressure last week, is back near breakeven.
This week's summary
Kyverna Therapeutics' decline is pausing: after last week's 12.2% plunge, the week just closed was essentially flat, with 63% of volume swinging back to the buy side and a double bottom holding firm in the 7.1-7.2 area. The picture stays technically neutral, with seller dominance clearly fading; the short, comfortably ahead in recent weeks, is back near breakeven.
IQS Phase
69
in tension
Signal Strength
23
decline losing steam
Sizing
MINIMUM
Ranking
#101 / 141
US stocks
Trade P&L %
+0.80%
from signal to today
Rank position
ranks 101st among the 141 sell signals for US stocks in our ranking, with a signal strength of 23 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
KYTX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content